Article
SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients.
Chinese journal of cancer - 14 Dec 2015
Wang Yi-Wei, Zhang Shao-Dan, Xue Wen-Ji, Zhu Mei-Ling, Zheng Lei-Zhen
Abstract excerpt
BACKGROUND: Serine hydroxymethyltransferase 1 (SHMT1) is a key enzyme in the folate metabolic pathway that plays an important role in biosynthesis by providing one carbon unit. SHMT1 C1420T may lead to the abnormal biosynthesis involved in DNA synthesis and methylation, and it may eventually increase cancer susceptibility. Many epidemiologic studies have explored the association between C1420T polymorphism and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
